HealthEquity, Inc. (NASDAQ:HQY – Free Report) – Equities researchers at Zacks Research lifted their Q2 2025 earnings estimates for HealthEquity in a research note issued to investors on Wednesday, June 26th. Zacks Research analyst R. Department now expects that the company will post earnings of $0.52 per share for the quarter, up from their prior estimate of $0.51. The consensus estimate for HealthEquity’s current full-year earnings is $2.12 per share. Zacks Research also issued estimates for HealthEquity’s Q3 2025 earnings at $0.54 EPS, Q4 2025 earnings at $0.56 EPS, Q2 2026 earnings at $0.65 EPS, Q3 2026 earnings at $0.66 EPS and FY2027 earnings at $3.52 EPS.
HealthEquity (NASDAQ:HQY – Get Free Report) last issued its earnings results on Monday, June 3rd. The company reported $0.55 earnings per share for the quarter, topping analysts’ consensus estimates of $0.47 by $0.08. The business had revenue of $287.60 million for the quarter, compared to the consensus estimate of $278.78 million. HealthEquity had a net margin of 7.71% and a return on equity of 7.77%.
View Our Latest Report on HealthEquity
HealthEquity Trading Up 0.5 %
HQY stock opened at $86.62 on Monday. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.39 and a quick ratio of 4.39. The company has a fifty day moving average price of $81.14 and a two-hundred day moving average price of $78.32. HealthEquity has a one year low of $61.32 and a one year high of $88.26. The stock has a market cap of $7.54 billion, a price-to-earnings ratio of 94.15, a price-to-earnings-growth ratio of 1.45 and a beta of 0.55.
Insider Buying and Selling
In related news, CEO Jon Kessler sold 32,326 shares of the company’s stock in a transaction dated Monday, June 24th. The shares were sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the completion of the sale, the chief executive officer now owns 232,176 shares of the company’s stock, valued at $19,231,138.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other HealthEquity news, CEO Jon Kessler sold 32,326 shares of the business’s stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the completion of the transaction, the chief executive officer now owns 232,176 shares of the company’s stock, valued at $19,231,138.08. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Vice Chairman Stephen Neeleman sold 2,080 shares of the business’s stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $85.01, for a total value of $176,820.80. Following the transaction, the insider now directly owns 90,515 shares of the company’s stock, valued at approximately $7,694,680.15. The disclosure for this sale can be found here. Insiders sold 34,806 shares of company stock valued at $2,888,383 over the last quarter. 2.20% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of HQY. Envestnet Asset Management Inc. raised its holdings in HealthEquity by 41.2% in the 3rd quarter. Envestnet Asset Management Inc. now owns 84,617 shares of the company’s stock valued at $6,181,000 after buying an additional 24,685 shares during the last quarter. Mariner LLC raised its holdings in HealthEquity by 2.4% in the 3rd quarter. Mariner LLC now owns 14,983 shares of the company’s stock valued at $1,095,000 after buying an additional 345 shares during the last quarter. Natixis Advisors L.P. raised its holdings in HealthEquity by 7.2% in the 3rd quarter. Natixis Advisors L.P. now owns 17,664 shares of the company’s stock valued at $1,290,000 after buying an additional 1,180 shares during the last quarter. O Shaughnessy Asset Management LLC raised its holdings in HealthEquity by 22.5% in the 3rd quarter. O Shaughnessy Asset Management LLC now owns 6,201 shares of the company’s stock valued at $453,000 after buying an additional 1,141 shares during the last quarter. Finally, Gotham Asset Management LLC bought a new position in HealthEquity in the 3rd quarter valued at approximately $1,103,000. Institutional investors and hedge funds own 99.55% of the company’s stock.
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
- Five stocks we like better than HealthEquity
- How to Invest in the Best Canadian StocksĀ
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- How Can Investors Benefit From After-Hours Trading
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- 3 Warren Buffett Stocks to Buy Now
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.